C - Chemistry – Metallurgy – 12 – P
Patent
C - Chemistry, Metallurgy
12
P
C12P 21/02 (2006.01) A61K 35/26 (2006.01) A61K 38/10 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) C07K 7/08 (2006.01) C07K 14/725 (2006.01) C07K 16/28 (2006.01) C12N 5/02 (2006.01) C12P 21/08 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2064077
Peptides and pharmaceutical compositions comprising immunogenic peptides of a marker T cell receptor (TCR) character- istic of an immune-related disease, capable of preventing, suppressing, or treating the disease, are disclosed. In a preferred em- bodiment, the amino acid sequence of the peptide corresponds to at least part of a complementary determining region (CDR) or a hypervariable region of the TCR. Antibodies and/or T cells immunologically reactive to the TCR peptide capable of preventing, suppressing, or treating an immune-related disease by passive transfer are also disclosed.
Gowling Lafleur Henderson Llp
The Immune Response Corporation
Vandenbark Arthur A.
LandOfFree
T cell receptor peptides as therapeutics for autoimmune and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with T cell receptor peptides as therapeutics for autoimmune and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and T cell receptor peptides as therapeutics for autoimmune and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1814085